Document Detail


Pisa syndrome in a cohort of Alzheimer's disease patients.
MedLine Citation:
PMID:  15691290     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Three Alzheimer's disease patients with Pisa syndrome were presented. These patients were treated with cholinesterase inhibitors within a post-marketing surveillance study. The clinical and pharmacological histories of these patients suggest a relation between cholinesterase inhibitors and the pleurothotonus. The diffuse use of cholinesterase inhibitors in the treatment of dementia may cause an increasing number of Pisa syndrome cases.
Authors:
N Vanacore; G Suzzareddu; M Maggini; A Casula; P Capelli; R Raschetti
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Acta neurologica Scandinavica     Volume:  111     ISSN:  0001-6314     ISO Abbreviation:  Acta Neurol. Scand.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-04     Completed Date:  2005-03-31     Revised Date:  2006-08-16    
Medline Journal Info:
Nlm Unique ID:  0370336     Medline TA:  Acta Neurol Scand     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  199-201     Citation Subset:  IM    
Affiliation:
National Centre of Epidemiology, National Institute of Health, Rome, Italy. nicola.vanacore@iss.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Alzheimer Disease / complications*,  drug therapy,  epidemiology
Cholinesterase Inhibitors / adverse effects
Dystonia / chemically induced,  epidemiology,  etiology*
Female
Humans
Incidence
Syndrome
Chemical
Reg. No./Substance:
0/Cholinesterase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Multiple sclerosis: long-term remission after a high dose of cyclophosphamide.
Next Document:  Coeliac disease, unilateral occipital calcifications, and drug-resistant epilepsy: successful lesion...